Patients don’t experience obesity in isolation, and clinical trials shouldn’t be designed as if they do. In this Applied Clinical Trials article, Natalia Castro and Casey Ustick examine how obesity studies can better reflect the realities of comorbidities, concurrent therapies and ongoing patient-provider relationships, helping sponsors build trials that support engagement, data quality and real-world applicability. Read the full article here.
Authors:
Natalia Castro
Executive Director, Cardiovascular & Metabolic
Casey Ustick
Therapeutic Strategy Lead, Metabolic
